Lloyd A. Rowland, General Counsel: CytomX Therapeutics CTMX Sell · Filed 25/03/20

Trade details

Type: Insider sale
Amount: $6,121.8
Shares · price: 10,203 sh · $0.60 a share
Held after: 120,594 sh
Stock: CytomX Therapeutics CTMX
Person: Lloyd A. RowlandGeneral Counsel
Trade date: 25/03/18
Filed: 25/03/20
Days to filing: 2 days

Sold 7.8% of holdings

Share of holding sold: 7.8%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/16~25/04/17

Lloyd A. Rowland's recent trades

Lloyd A. RowlandGeneral Counsel
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,143
4,181 sh
$5,143
Filed 24/08/22
Traded 24/08/20
Lloyd A. RowlandGeneral Counsel
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$11K
5,268 sh
$11K
Filed 24/03/21
Traded 24/03/19
Lloyd A. RowlandGeneral Counsel
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,626
4,077 sh
$5,626
Filed 23/12/22
Traded 23/12/20
Lloyd A. RowlandGeneral Counsel
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$7,132
5,486 sh
$7,132
Filed 23/09/22
Traded 23/09/22
Lloyd A. RowlandGeneral Counsel
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$4,033
2,037 sh
$4,033
Filed 23/03/20
Traded 23/03/16